Make sure you follow our Twitter feed and subscribe to our LinkedIn webpage!
Cell Therapies Pty Ltd will be attending the Phacilitate Leaders World Conference, part of Advanced Therapies Week, in Miami from 21-24 January 2020. Nathan Smith, our Project Portfolio Manager responsible [...]
Cell Therapies Pty Ltd will be attending the International Society for Cell & Gene Therapy (ISCT) Annual Meeting in Paris from 27-30 May 2020. We will be sponsoring the Global [...]
For the first time in Australia, Cell Therapies Pty Ltd (CTPL), a recognised leader in the manufacturing and distribution of cell-based therapies, has been granted a product class (T-cells) GMP [...]
Cell Therapies Pty Ltd hosted a very unique breakfast session at ISCT on Thursday 30th May. Our own Nathan Smith chaired this event, which gave a deep look into clinical [...]
Cell Therapies Pty Ltd will be holding an Open House on Tuesday, 28 May 2019 at 17:30 in conjunction with the 2019 International Society for Cell and Gene Therapy (ISCT) [...]
To view the video, click here [...]
(19 Dec 18) Novartis Australia has announced the TGA approval of Kymriah® (tisagenlecleucel), for the treatment of two types of aggressive cancers. This one-time treatment is called “CAR-T” cellular therapy, [...]
Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Dawn Driscoll as its new Chief Executive Officer. Dawn is highly experienced in the cellular therapy industry and [...]
Melbourne, Australia 26 June 2017: Cell Therapies has been awarded $1,000,000 in funding by the Australian Government Department of Industry, Innovation and Science through the Global Innovation Linkages programme. On [...]
Melbourne, Australia 20 February 2017: Cell Therapies commitment to, and excellence in, bringing innovative cellular therapies into clinical practise has been recognised with an IMAPAC Asia-Pacific Bioprocessing Excellence Award. Managing [...]
Melbourne, Australia, 11 October 2016: Cell Therapies Pty Ltd (CTPL) is pleased to announce that CEO and Managing Director Dr Tim Oldham has been elected to the Board of the [...]
CT’s contribution to ISCT 2016 Representatives from Cell Therapies presented at ISCT Singapore on the following topics: Apheresis – Douglas Watson, Cell Therapy Specialist Initial Comparison of 3 apheresis platforms [...]
Melbourne 8 Feb 2016: Cell collection via apheresis is the starting point for manufacture of many cellular therapies, including most immuno-therapies. The high patient-to-patient variability, coupled with the specialised skills [...]
REFORM NEEDED TO FULFILL OUR BIOTECH POTENTIAL is an article by AusBiotech’s Chief Executive, Dr Anna Lavelle, published in Melbourne’s Herald Sun on the 25 September 2015. Dr Lavelle’s article [...]
Melbourne and Kuala Lumpur 30 Sep 2015: Cell Therapies Pty Ltd (CTPL) has today received official notification from the Malaysian Government and Malaysian Biotechnology Corporation (BiotechCorp) that its Malaysian subsidiary, Cell Therapies [...]
Cell Therapies’ Chief Scientific Officer, Dr Dominic Wall will participate in AusBiotech2015 as part of the Regenerative Medicine Forum. He is quoted today in an article by Sue Dunlevy highlighting [...]
Cell Therapies Pty Ltd has been profiled in Australian Biotechnology’s most recent edition featuring advanced manufacturing. As cellular therapies transform healthcare for many unmet medical needs, new manufacturing capacity with [...]
Nagoya, Japan and Melbourne, Australia: 28 April 2015: PharmaBio Ltd and Cell Therapies Pty Ltd announce that they have entered a memorandum of understanding to establish an alliance that will [...]
Cell Therapies Pty Ltd (Cell Therapies), a leading manufacturer and distributor of cellular therapies in the Asia-Pacific region, is pleased to announce significant change to board structure in anticipation of [...]
Melbourne, Australia 21 April 2014: Cell Therapies Pty Ltd (Cell Therapies), the leading manufacturer and distributor of cellular therapies in Asia Pacific, has appointed Dr Tim Oldham as CEO to [...]
Cell Therapies Pty Ltd is an essential partner in a new $60 million Commonwealth Government project designed to help translate promising cellular therapy treatments from the lab [...]
Cell Therapies P/L has become an essential partner in the recently approved Cooperative Research Center for Cell Therapies Manufacturing (CRC-CTM). The combination of world leading academic researchers with local and [...]
Cell Therapies Pty Ltd is pleased to announce that Dr Christian Behrenbruch has been appointed as Chairman of the Melbourne-based life sciences company. Dr Behrenbruch will also serve as a [...]
Cell Therapies has announced an exclusive licensing agreement with South Korean-based Medipost for the distribution and manufacture of its innovative product Cartistem® a cellular treatment for osteoarthritis (OA) and focal [...]
